DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Bogdahn U, Hau P, Stockhammer G. , et al; Trabedersen Glioma Study Group.
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.
Neuro Oncol 2011;
13 (01) 132-142
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.